Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common chronic childhood disorders, and its prevalence is on the rise. National survey data from 2016 indicate that 9.4 percent of children in the United States ages 2 to 17 have had an ADHD diagnosis, including 2.4 percent of children 2 to 5 years of age. In that national survey, 8.4 percent of children ages 2 to 17 currently had ADHD, representing 5.4 million children. Among children and adolescents with current ADHD, almost two-thirds were taking medication, and approximately half had received behavioral treatment for ADHD in the past year. Nearly one quarter had received neither type of treatment of ADHD.
Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood. Children with ADHD may have difficulty controlling their behavior in school and social settings and often fail to achieve their full academic potential. Additionally, ADHD is frequently present with other psychiatric disorders.
ADHD가있는 아동의 효과적인 장기 관리의 핵심은 ADHD 치료 경험이있는 임상의와 지속적으로 치료하는 것입니다. 후속 세션의 빈도와 기간은 ADHD 증상의 심각성에 따라 각 가족과 아동에 따라 개별화되어야합니다. 다른 정신 질환의 동반 이환 정도; 치료에 대한 반응; 그리고 가정, 학교, 직장 또는 또래 관련 활동의 장애 정도.
진단 및 치료 지침
- 미국 소아과 아카데미 ADHD 지침
- American Academy of Pediatrics Guideline Supplement-Algorithm
- American Academy of Pediatrics Guideline Supplement-Barriers
- ADHD 약물 치료 알고리즘
Healthcare Effectiveness Data and Information Set (HEDIS®)1 Tip Sheets
1 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).